Biomarkers for sarcopenia, muscle mass, muscle strength, and physical performance: an umbrella review

Shranjeno v:
Bibliografske podrobnosti
izdano v:Journal of Translational Medicine vol. 23, no. 1 (Dec 2025), p. 650
Glavni avtor: Liu, Gaoming
Drugi avtorji: Jiang, Shide, Xie, Wenqing, Liu, Xu, Yang, Guang, Lu, Wenhao, Li, Hengzhen, Liu, Zhi, Xiao, Wenfeng, Li, Yusheng
Izdano:
Springer Nature B.V.
Teme:
Online dostop:Citation/Abstract
Full Text
Full Text - PDF
Oznake: Označite
Brez oznak, prvi označite!

MARC

LEADER 00000nab a2200000uu 4500
001 3290959820
003 UK-CbPIL
022 |a 1479-5876 
024 7 |a 10.1186/s12967-025-06575-3  |2 doi 
035 |a 3290959820 
045 2 |b d20251201  |b d20251231 
084 |a 67196  |2 nlm 
100 1 |a Liu, Gaoming  |u Central South University, Department of Orthopedics, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
245 1 |a Biomarkers for sarcopenia, muscle mass, muscle strength, and physical performance: an umbrella review 
260 |b Springer Nature B.V.  |c Dec 2025 
513 |a Journal Article 
520 3 |a BackgroundBiomarkers in sarcopenia have garnered increasing interest. This study aims to systematically identify biomarkers with potential diagnostic significance for sarcopenia, as well as those exhibiting correlations with sarcopenia, particularly biomarkers reporting quantitative pooled data.MethodsThis umbrella review adhered to the PRISMA 2020 guidelines. Data sources including PubMed, the Cochrane Library, Embase, Scopus, and Web of Science were searched from the inception of data to April 7, 2025. The AMSTAR 2 tool and QUADAS-2 tool was utilized to assess the methodological quality of including studies, while the GRADE approach was used to evaluate the quality of evidence in these studies.ResultsA total of 22 studies were included. The identified biomarkers encompass inflammatory, metabolic, hormonal, amino acid-related, genetic, and other categories. The evidence quality for most biomarkers was rated as very low. The creatinine to cystatin C (Cr/CysC) ratio emerged as the most frequently utilized diagnostic biomarker, demonstrating moderate diagnostic accuracy. However, its diagnostic performance exhibited variability across different diagnostic criteria. Biomarkers associated with sarcopenia predominantly demonstrated weak or negligible inverse correlations. Inflammatory biomarkers underwent the most comprehensive investigation. Patients with sarcopenia exhibited elevated interleukin-6 (IL-6), C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-α) levels compared to controls, with these markers showing post-intervention improvement. Some metabolic and amino acid biomarkers were found to be lower in patients with sarcopenia than in the control group.ConclusionThe Cr/CysC ratio demonstrates moderate diagnostic accuracy and represents the most frequently utilized diagnostic biomarker for sarcopenia. Inflammatory biomarkers constitute the predominant biomarkers and exhibit general elevation in sarcopenia patients. Following sarcopenia interventions, alterations in biomarker expression levels are observed, suggesting novel therapeutic applications for these biomarkers. 
653 |a Accuracy 
653 |a Sarcopenia 
653 |a Muscle strength 
653 |a Amino acids 
653 |a Ratios 
653 |a Biomarkers 
653 |a Diagnostic tests 
653 |a Cystatin C 
653 |a Working groups 
653 |a Tumor necrosis factor-α 
653 |a Interleukin 6 
653 |a Meta-analysis 
653 |a Creatinine 
653 |a C-reactive protein 
653 |a Therapeutic applications 
653 |a Inflammation 
700 1 |a Jiang, Shide  |u The Central Hospital of Yongzhou, Department of Orthopedics, Yongzhou, China (GRID:grid.216417.7) 
700 1 |a Xie, Wenqing  |u Central South University, Department of Orthopedics, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
700 1 |a Liu, Xu  |u Central South University, Department of Orthopedics, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
700 1 |a Yang, Guang  |u Central South University, Department of Orthopedics, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
700 1 |a Lu, Wenhao  |u Central South University, Department of Orthopedics, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
700 1 |a Li, Hengzhen  |u Central South University, Department of Orthopedics, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
700 1 |a Liu, Zhi  |u Central South University, Department of Orthopedics, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
700 1 |a Xiao, Wenfeng  |u Central South University, Department of Orthopedics, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
700 1 |a Li, Yusheng  |u Central South University, Department of Orthopedics, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164); Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164) 
773 0 |t Journal of Translational Medicine  |g vol. 23, no. 1 (Dec 2025), p. 650 
786 0 |d ProQuest  |t Health & Medical Collection 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3290959820/abstract/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text  |u https://www.proquest.com/docview/3290959820/fulltext/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3290959820/fulltextPDF/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch